NCT04587921 (MoxiCov) is a NA clinical trial of Digital oximeter monitoring in Oximetry, sponsored by University of Sao Paulo General Hospital.

Who is sponsoring NCT04587921?

NCT04587921 is sponsored by University of Sao Paulo General Hospital.

What drugs are being tested in NCT04587921?

Interventions in NCT04587921: Digital oximeter monitoring.

What condition does NCT04587921 study?

NCT04587921 studies Oximetry, Covid19.

Is NCT04587921 still recruiting?

NCT04587921 is currently status unknown. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT04587921: MoxiCov

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19

Status unknown NA Last updated 14 October 2020

What this trial tests

NA trial testing Digital oximeter monitoring in Oximetry in 90 participants. Status unknown.

Timeline

22 June 2020

Primary endpoint
22 January 2021

22 June 2021

Quick facts

Lead sponsor	University of Sao Paulo General Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	90
Start date	22 June 2020
Primary completion	22 January 2021
Estimated completion	22 June 2021
Sites	1 location across Brazil

Drugs / interventions tested

Digital oximeter monitoring

Conditions studied

Oximetry — all drugs for Oximetry →
Covid19 — all drugs for Covid19 →

Sponsor

University of Sao Paulo General Hospital

Who can join

18 and older, any sex, with Oximetry or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of MoxiCov is to monitor the oximetry of patients admitted to the Covid nursery to provide a more detailed assistance expecting to reduce the amount of hypoxia in these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Sao Paulo General Hospital trials

Trials by the same sponsor.

NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04587921 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04587921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing